Rights and permissions
About this article
Cite this article
Enfuvirtide response maintained at 48 weeks. Inpharma Wkly. 1385, 9 (2003). https://doi.org/10.2165/00128413-200313850-00020
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200313850-00020